CoChat

Defective Cell Cycle Checkpoint Functions in Melanoma Are Associated with Altered Patterns of Gene Expression

Open access

The DOI matches its Crossref record; 68 of the 70 references it cites were found in a registry or an index.

Abstract

Defects in DNA damage responses may underlie genetic instability and malignant progression in melanoma. Cultures of normal human melanocytes (NHMs) and melanoma lines were analyzed to determine whether global patterns of gene expression could predict the efficacy of DNA damage cell cycle checkpoints that arrest growth and suppress genetic instability. NHMs displayed effective G1 and G2 checkpoint responses to ionizing radiation-induced DNA damage. A majority of melanoma cell lines (11/16) displayed significant quantitative defects in one or both checkpoints. Melanomas with B-RAF mutations as a class displayed a significant defect in DNA damage G2 checkpoint function. In contrast the epithelial-like subtype of melanomas with wild-type N-RAS and B-RAF alleles displayed an effective G2 checkpoint but a significant defect in G1 checkpoint function. RNA expression profiling revealed that melanoma lines with defects in the DNA damage G1 checkpoint displayed reduced expression of p53 transcriptional targets, such as CDKN1A and DDB2, and enhanced expression of proliferation-associated genes, such as CDC7 and GEMININ. A Bayesian analysis tool was more accurate than significance analysis of microarrays for predicting checkpoint function using a leave-one-out method. The results suggest that defects in DNA damage checkpoints may be recognized in melanomas through analysis of gene expression.

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.jid.5700935

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 68 references

Cited by

Metadata

Authors
Kaufmann, W. K., Nevis, K. R., Qu, P., Ibrahim, J. G., Zhou, T., Zhou, Y., Simpson, D. A., Helms-Deaton, J., Cordeiro-Stone, M., Moore, D. T., Thomas, N. E., Hao, H., Liu, Z., Shields, J. M., Scott, G. A., & Sharpless, N. E.
Affiliations
  • University of North Carolina at Chapel Hill (US)
  • University of Rochester Medicine (US)
Corresponding author
Kaufmann, William K.
Venue
Journal of Investigative Dermatology
Publisher
Elsevier BV
Published
2008-01
Volume
128
Issue
1
Pages
175-187
ISSN
0022-202X (ISSN-L)
OpenAlex
W1981058260
Cited by
65
References
70
Citations by year
2026: 2 · 2025: 1 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 1 · 2019: 1 · 2018: 5 · 2017: 3 · 2016: 4 · 2015: 6 · 2014: 5 · 2013: 7 · 2012: 5
FWCI
2.12
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Investigative Dermatology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
  • UNC Libraries
Funders
  • National Cancer Institute (CA-160-86, R01CA112243, T32CA106209, P30CA016086)
  • National Institute of General Medical Sciences (R01GM070335)
  • National Institute of Environmental Health Sciences (ES07017, U19ES011391, ES-11391, ES 10126, T32ES007017, P30ES010126)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords
melanoma, DNA damage response, cell cycle checkpoints, G1/S checkpoint, G2 checkpoint, genomic instability, BRAF mutation, NRAS, p21, DDB2, CDC7, geminin, gene expression profiling, ionizing radiation, melanocytes, Bayesian analysis, significance analysis of microarrays
MeSH terms
Cells, Cultured, DNA Damage, DNA-Binding Proteins, Humans, Melanocytes, Melanoma, Mutation, Phosphorylation, Tumor Suppressor Protein p53, G1 Phase, G2 Phase, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Gene Expression Profiling, Chromosomal Instability, Cell Line, Tumor, Proto-Oncogene Proteins B-raf, Cyclin-Dependent Kinase Inhibitor p21, DNA Breaks, Double-Stranded, Geminin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.